HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chie Kudo-Saito Selected Research

Biological Products

2/2022Targeting AURKA in treatment of peritoneal tumor dissemination in gastrointestinal cancer.
1/2022Blocking FSTL1 boosts NK immunity in treatment of osteosarcoma.
2/2021Targeting Oncoimmune Drivers of Cancer Metastasis.
1/2021CD11b+CTLA4+ myeloid cells are a key driver of tumor evasion in colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chie Kudo-Saito Research Topics

Disease

28Neoplasms (Cancer)
02/2022 - 02/2004
13Neoplasm Metastasis (Metastasis)
01/2022 - 12/2006
2Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 02/2004
2Melanoma (Melanoma, Malignant)
09/2012 - 03/2009
1Ascites
02/2022
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
02/2022
1Polyploidy
01/2020
1Adenocarcinoma
11/2017
1Inflammation (Inflammations)
01/2017
1Fibrosis (Cirrhosis)
01/2017
1Bronchiolitis Obliterans Syndrome
01/2017
1Colonic Neoplasms (Colon Cancer)
03/2014
1Breast Neoplasms (Breast Cancer)
10/2013
1Fowlpox
12/2007
1Choroidal Neovascularization
10/2007
1Renal Cell Carcinoma (Grawitz Tumor)
03/2007

Drug/Important Bio-Agent (IBA)

7AntigensIBA
12/2007 - 02/2004
6VaccinesIBA
12/2007 - 02/2004
4Biological ProductsIBA
02/2022 - 01/2021
3FollistatinIBA
01/2021 - 10/2013
3ChemokinesIBA
11/2017 - 01/2013
3Monoclonal AntibodiesIBA
01/2016 - 06/2005
3CytokinesIBA
05/2013 - 09/2007
3CateninsIBA
01/2013 - 03/2011
3Neoplasm Antigens (Tumor Antigens)IBA
12/2006 - 10/2004
3AutoantigensIBA
01/2006 - 02/2004
2Activated-Leukocyte Cell Adhesion Molecule (Neurolin)IBA
01/2016 - 10/2013
2Proteins (Proteins, Gene)FDA Link
03/2014 - 11/2013
2Small Interfering RNA (siRNA)IBA
04/2013 - 03/2009
2Interleukin-2 (IL2)IBA
12/2007 - 03/2007
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
06/2006 - 03/2005
2Therapeutic UsesIBA
06/2006 - 03/2005
1MLN 8237IBA
02/2022
1Aurora Kinase AIBA
02/2022
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2021
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
01/2021
1Immune Checkpoint InhibitorsIBA
01/2021
1Interleukin-33IBA
01/2020
1Granzymes (Granzyme)IBA
11/2017
1LigandsIBA
11/2017
1Interferon-gamma (Interferon, gamma)IBA
11/2017
14-phenylbutyric acid (Buphenyl)FDA Link
01/2017
1Peptides (Polypeptides)IBA
03/2014
1Messenger RNA (mRNA)IBA
03/2014
1Adapalene (Differin)FDA LinkGeneric
03/2014
1Glycoproteins (Glycoprotein)IBA
10/2013
1Lipocalin-2IBA
04/2013
1Chemotactic FactorsIBA
04/2013
1Interleukin-10 (Interleukin 10)IBA
09/2012
1Transcription Factors (Transcription Factor)IBA
03/2009
1Synthetic Vaccines (Recombinant Vaccines)IBA
12/2007
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
10/2007
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
03/2007
1Interleukin-15 (Interleukin 15)IBA
03/2007
1InterleukinsIBA
03/2007
1Cell Wall SkeletonIBA
12/2006
14-1BB Ligand (4 1BB Ligand)IBA
06/2006
1CD58 Antigens (LFA-3)IBA
06/2006
1Carcinoembryonic AntigenIBA
03/2005
1Cancer VaccinesIBA
03/2005
1EpitopesIBA
03/2005

Therapy/Procedure

11Therapeutics
01/2022 - 02/2004
8Immunotherapy
05/2013 - 01/2006
2Aftercare (After-Treatment)
01/2022 - 01/2020
2Cryosurgery
01/2016 - 12/2006
2Molecular Targeted Therapy
05/2013 - 01/2013
1Hematopoietic Stem Cell Transplantation
01/2017